The programme committee consisted of a diverse group of experts who represent ESCMID in scientific collaboration with the European Society for Paediatric Infectious Diseases (ESPID), the European Association of Hospital Pharmacists (EAHP), the European Medicines Agency (EMA) or are independent. This blend of expertise and backgrounds ensured a wide range of perspectives when addressing the creation of new vaccines and the challenges associated with their use and distribution.
Registration for ESCMID Global 2026 in Munich is now open.
Register now to get the early registration fee and attend the world’s most eminent event in the field of infection.